Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

185

HTML

1403

Figures (1-1)

186

Tables (1-4)

157

Sum=1931

Jul 14, 2011 (publication date) through Jul 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jul 14, 2011; 17(26): 3145-3150
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3145

Table 1 Baseline data of the patients

Variables	Values
Mean age (yr)	57.2
Cases of HBV-related liver disease	61.0
Cases of HCV-related liver disease	0.0
Mean AST (U/L)	43.4
Mean ALT (U/L)	49.5
Mean total bilirubin (μmol/L)	26.2
Mean AFP (ng/mL)	963.9
Mean tumor size (cm)	8.3

HBV: Hepatitis B virus; HCV: Hepatitis C virus; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; AFP: α-fetoprotein.

Citation: Gao F, Gu YK, Fan WJ, Zhang L, Huang JH. Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma. World J Gastroenterol 2011; 17(26): 3145-3150
URL: https://www.wjgnet.com/1007-9327/full/v17/i26/3145.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i26.3145